CliffBio
small molecule

TESTOSTERONE

TESTOSTERONE

Loss of exclusivity—loss of exclusivity
CompanyCipla →See this company's full patent-cliff portfolio

Drug detail

Brand nameTESTOSTERONE
Active ingredientTESTOSTERONE
Strength30MG/1.5ML ACTUATION
Dosage formSOLUTION, METERED
RouteTRANSDERMAL
ModalitySmall molecule
FDA approvalJanuary 2018
Marketing statusRX

More from Cipla

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

TESTOSTERONE patent cliff — loss of exclusivity — | CliffBio